A Novato startup company that is researching the connection between Alzheimer’s disease and a bacteria found in gum disease has received backing from a local venture capital firm.
Marin Sonoma Impact Ventures announced its investment in Lighthouse Pharmaceuticals, based at the Buck Institute for Research on Aging, on June 15. Zachary Kushel, founder and managing partner of the investment firm, said Lighthouse is the first medical biotech firm working on drug treatments in its portfolio.
Lighthouse is one of 20 startups in the North Bay that the firm has invested in since its founding in 2021, Kushel said…